Frequency and Severity of Pleural Effusion Associated With the Use of Dasatinib in Patients With Chronic Myeloid Leukemia. A Descriptive, Mexican Multicenter Study
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Leukemia
Related studies linked through entity extraction aliases.
Immunotherapy With CD19 CAR T-cells for B-Cell Lymphoma, ALL and CLL
- Status
- UNKNOWN
- Phase
- PHASE1
CD19-directed CAR T Cells Therapy in Relapsed/Refractory B Cell Malignancy
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Phase I/II, Study of Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) + Sorafenib in Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Illness Management and Parental Adjustment to Cancer Treatment
- Status
- COMPLETED
- Phase
- NA
Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children
- Status
- TERMINATED
- Phase
- PHASE1
Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Yoga to Alleviate Fatigue, Anxiety and Pain in Adolescents During Treatment for Lymphoma or Leukemia
- Status
- TERMINATED
- Phase
- NA
Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS)
- Status
- TERMINATED
- Phase
- PHASE2
Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention
- Status
- COMPLETED
- Phase
- PHASE1
Urelumab (CD137 mAb) With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
An Open-label Phase II Study of Lorvotuzumab Mertansine
- Status
- COMPLETED
- Phase
- PHASE2
Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers
- Status
- COMPLETED
- Phase
- NA
A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML
- Status
- COMPLETED
- Phase
- PHASE1